 | • レポートコード：MRC2-11QY04205 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はペプチド胃腸障害治療薬のグローバル市場について調査・分析したレポートです。種類別（テデュグルチド、リナクロチド、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ペプチド胃腸障害治療薬の競争状況、市場シェア ・世界のペプチド胃腸障害治療薬市場：種類別市場規模 2015年-2020年（テデュグルチド、リナクロチド、その他） ・世界のペプチド胃腸障害治療薬市場：種類別市場規模予測 2021年-2026年（テデュグルチド、リナクロチド、その他） ・世界のペプチド胃腸障害治療薬市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界のペプチド胃腸障害治療薬市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米のペプチド胃腸障害治療薬市場分析：米国、カナダ ・ヨーロッパのペプチド胃腸障害治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのペプチド胃腸障害治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のペプチド胃腸障害治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのペプチド胃腸障害治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Takeda、Ironwood Pharmaceuticals、Astellas Pharma、Allergan、Takeda Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas.
Market Analysis and Insights: Global Peptide Based Gastrointestinal Disorders Therapeutics Market
The global Peptide Based Gastrointestinal Disorders Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Peptide Based Gastrointestinal Disorders Therapeutics Scope and Market Size
Peptide Based Gastrointestinal Disorders Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Peptide Based Gastrointestinal Disorders Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Takeda
Ironwood Pharmaceuticals
Astellas Pharma
Allergan
Takeda Pharmaceutical
…
Market segment by Type, the product can be split into
Teduglutide
Linaclotide
Others
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Peptide Based Gastrointestinal Disorders Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Teduglutide
1.4.3 Linaclotide
1.4.4 Others
1.5 Market by Application
1.5.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Perspective (2015-2026)
2.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Growth Trends by Regions
2.2.1 Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Peptide Based Gastrointestinal Disorders Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Peptide Based Gastrointestinal Disorders Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Peptide Based Gastrointestinal Disorders Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Market Size
3.1.1 Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Concentration Ratio
3.2.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Peptide Based Gastrointestinal Disorders Therapeutics Revenue in 2019
3.3 Peptide Based Gastrointestinal Disorders Therapeutics Key Players Head office and Area Served
3.4 Key Players Peptide Based Gastrointestinal Disorders Therapeutics Product Solution and Service
3.5 Date of Enter into Peptide Based Gastrointestinal Disorders Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020)
5.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2015-2020)
6.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in North America (2019-2020)
6.3 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020)
6.4 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2015-2020)
7.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020)
7.4 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2015-2020)
8.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in China (2019-2020)
8.3 China Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020)
8.4 China Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2015-2020)
9.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020)
9.4 Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2015-2020)
10.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2015-2020)
11.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in India (2019-2020)
11.3 India Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020)
11.4 India Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2015-2020)
12.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Takeda
13.1.1 Takeda Company Details
13.1.2 Takeda Business Overview
13.1.3 Takeda Peptide Based Gastrointestinal Disorders Therapeutics Introduction
13.1.4 Takeda Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020))
13.1.5 Takeda Recent Development
13.2 Ironwood Pharmaceuticals
13.2.1 Ironwood Pharmaceuticals Company Details
13.2.2 Ironwood Pharmaceuticals Business Overview
13.2.3 Ironwood Pharmaceuticals Peptide Based Gastrointestinal Disorders Therapeutics Introduction
13.2.4 Ironwood Pharmaceuticals Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020)
13.2.5 Ironwood Pharmaceuticals Recent Development
13.3 Astellas Pharma
13.3.1 Astellas Pharma Company Details
13.3.2 Astellas Pharma Business Overview
13.3.3 Astellas Pharma Peptide Based Gastrointestinal Disorders Therapeutics Introduction
13.3.4 Astellas Pharma Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020)
13.3.5 Astellas Pharma Recent Development
13.4 Allergan
13.4.1 Allergan Company Details
13.4.2 Allergan Business Overview
13.4.3 Allergan Peptide Based Gastrointestinal Disorders Therapeutics Introduction
13.4.4 Allergan Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020)
13.4.5 Allergan Recent Development
13.5 Takeda Pharmaceutical
13.5.1 Takeda Pharmaceutical Company Details
13.5.2 Takeda Pharmaceutical Business Overview
13.5.3 Takeda Pharmaceutical Peptide Based Gastrointestinal Disorders Therapeutics Introduction
13.5.4 Takeda Pharmaceutical Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020)
13.5.5 Takeda Pharmaceutical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Peptide Based Gastrointestinal Disorders Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Peptide Based Gastrointestinal Disorders Therapeutics Revenue
Table 3. Ranking of Global Top Peptide Based Gastrointestinal Disorders Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Teduglutide
Table 6. Key Players of Linaclotide
Table 7. Key Players of Others
Table 8. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Regions (2015-2020)
Table 12. Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Peptide Based Gastrointestinal Disorders Therapeutics Market Growth Strategy
Table 18. Main Points Interviewed from Key Peptide Based Gastrointestinal Disorders Therapeutics Players
Table 19. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 20. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Players (2015-2020)
Table 21. Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Based Gastrointestinal Disorders Therapeutics as of 2019)
Table 22. Global Peptide Based Gastrointestinal Disorders Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Peptide Based Gastrointestinal Disorders Therapeutics Product Solution and Service
Table 25. Date of Enter into Peptide Based Gastrointestinal Disorders Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 28. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Share by Type (2015-2020)
Table 29. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Type (2021-2026)
Table 30. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Share by Application (2015-2020)
Table 31. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 32. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Share by Application (2021-2026)
Table 33. North America Key Players Peptide Based Gastrointestinal Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Peptide Based Gastrointestinal Disorders Therapeutics Market Share (2019-2020)
Table 35. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 36. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2015-2020)
Table 37. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 38. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2015-2020)
Table 39. Europe Key Players Peptide Based Gastrointestinal Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Peptide Based Gastrointestinal Disorders Therapeutics Market Share (2019-2020)
Table 41. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2015-2020)
Table 43. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2015-2020)
Table 45. China Key Players Peptide Based Gastrointestinal Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 46. China Key Players Peptide Based Gastrointestinal Disorders Therapeutics Market Share (2019-2020)
Table 47. China Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 48. China Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2015-2020)
Table 49. China Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 50. China Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2015-2020)
Table 51. Japan Key Players Peptide Based Gastrointestinal Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Peptide Based Gastrointestinal Disorders Therapeutics Market Share (2019-2020)
Table 53. Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2015-2020)
Table 55. Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Peptide Based Gastrointestinal Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Peptide Based Gastrointestinal Disorders Therapeutics Market Share (2019-2020)
Table 59. Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2015-2020)
Table 61. Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2015-2020)
Table 63. India Key Players Peptide Based Gastrointestinal Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 64. India Key Players Peptide Based Gastrointestinal Disorders Therapeutics Market Share (2019-2020)
Table 65. India Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 66. India Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2015-2020)
Table 67. India Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 68. India Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Peptide Based Gastrointestinal Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Peptide Based Gastrointestinal Disorders Therapeutics Market Share (2019-2020)
Table 71. Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2015-2020)
Table 73. Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2015-2020)
Table 75. Takeda Company Details
Table 76. Takeda Business Overview
Table 77. Takeda Product
Table 78. Takeda Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020) (Million US$)
Table 79. Takeda Recent Development
Table 80. Ironwood Pharmaceuticals Company Details
Table 81. Ironwood Pharmaceuticals Business Overview
Table 82. Ironwood Pharmaceuticals Product
Table 83. Ironwood Pharmaceuticals Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020) (Million US$)
Table 84. Ironwood Pharmaceuticals Recent Development
Table 85. Astellas Pharma Company Details
Table 86. Astellas Pharma Business Overview
Table 87. Astellas Pharma Product
Table 88. Astellas Pharma Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020) (Million US$)
Table 89. Astellas Pharma Recent Development
Table 90. Allergan Company Details
Table 91. Allergan Business Overview
Table 92. Allergan Product
Table 93. Allergan Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020) (Million US$)
Table 94. Allergan Recent Development
Table 95. Takeda Pharmaceutical Company Details
Table 96. Takeda Pharmaceutical Business Overview
Table 97. Takeda Pharmaceutical Product
Table 98. Takeda Pharmaceutical Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020) (Million US$)
Table 99. Takeda Pharmaceutical Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Teduglutide Features
Figure 3. Linaclotide Features
Figure 4. Others Features
Figure 5. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Peptide Based Gastrointestinal Disorders Therapeutics Report Years Considered
Figure 10. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Regions: 2020 VS 2026
Figure 12. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Players in 2019
Figure 15. Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Based Gastrointestinal Disorders Therapeutics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Peptide Based Gastrointestinal Disorders Therapeutics Revenue in 2019
Figure 17. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
ペプチド代謝障害治療薬の世界市場（～2026年） A metabolic disorder can happen when abnormal chemical reactions in the body alter the normal metabolic process. It can also be defined as inherited single gene anomaly, most of which are autosomal recessive. Peptide therapeutics are used to treat metabolic disorders owing to their stability, effici…- ペプチド感染症治療薬の世界市場（～2026年） Peptide therapeutics are stable, safe, tolerable, possess selective nature, and effective. Hospital pharmacies segment enjoys the highest market share by revenue thereby dominating the global market. Market Analysis and Insights: Global Peptide Based Infection Therapeutics Market The global Peptide …
- ペプチド癌治療薬の世界市場（～2026年） Peptide is a compound that is created by artificial or natural biological chaining of amino acid monomers. In recent years, peptides have emerged as an effective therapeutic agent in treatment of various diseases, including cancer. Market Analysis and Insights: Global Peptide Based Cancer Therapeuti…
- ペプチド心血管治療薬の世界市場（～2026年） Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. Cardiovascular disease includes coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack). Other CVDs include stroke, heart failure, hypertensive heart diseas…
- 胃腸治療薬の世界市場（～2026年） Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarr…